Inventor
GRELL WOLFGANG
DE27 patents
⚠️ This page may combine multiple inventors who share the name “GRELL WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THOMAE GMBH DR K
17 patentsUS5232946AAug 3, 1993
Phenylethanolamines, their use as pharmaceuticals and as performance enhancers in animals
THOMAE GMBH DR K59 citations96
US5312924AMay 17, 1994
Phenylacetic acid benzylamides
THOMAE GMBH DR K41 citations94
US6143769ANov 7, 2000
Phenylacetic acid benzylamides
THOMAE GMBH DR K21 citations92
US5604225AFeb 18, 1997
Substituted thiazoles and oxazoles and 2-hydroxy-morpholines
THOMAE GMBH DR K21 citations92
US5519138AMay 21, 1996
Phenylalkyl derivatives, with pharmaceutical activity
THOMAE GMBH DR K20 citations92
US5216167AJun 1, 1993
Phenylacetic acid benzylamides
THOMAE GMBH DR K27 citations92
US4414225ANov 8, 1983
Azepine derivatives and their anti-thrombotic compositions and methods
THOMAE GMBH DR K31 citations92
US4735959AApr 5, 1988
Carboxylic acid amides and pharmaceutical compositions containing them
THOMAE GMBH DR K33 citations91
US4409220AOct 11, 1983
Fused-ring amino-pyrazines as bradycardiac agents
THOMAE GMBH DR K5 citations74
USRE37035EJan 30, 2001
Phenylacetic acid benzylamides
THOMAE GMBH DR K11 citations73
US5219852AJun 15, 1993
Substituted thiazoles and oxazoles and pharmaceutical compositions and methods thereof
THOMAE GMBH DR K7 citations73
US4886814ADec 12, 1989
Substituted thiazoles and oxazoles and 2-hydroxy-morpholines
THOMAE GMBH DR K8 citations73
US5457205AOct 10, 1995
Substituted thiazoles useful for treatment of diabetes
THOMAE GMBH DR K7 citations72
US4575504AMar 11, 1986
Thienothiazole derivatives
THOMAE GMBH DR K12 citations71
US5026702AJun 25, 1991
Morpholines and morpholine-N-oxides and pharmaceutical compositions containing these compounds
THOMAE GMBH DR K3 citations63
US5068325ANov 26, 1991
4,5,7,8-tetrahydro-6H-thiazolo[5,4-d]azepines, their preparation and their use as pharmaceutical compositions
THOMAE GMBH DR K5 citations62
US4486433ADec 4, 1984
Fused-ring amino-pyrazines as bradycardiacs
THOMAE GMBH DR K0 citations52
BOEHRINGER INGELHEIM PHARMA
6 patentsUS6169106B1Jan 2, 2001
Indolinones having kinase inhibitory activity
BOEHRINGER INGELHEIM PHARMA34 citations92
US6300342B1Oct 9, 2001
Antithrombotic phenylalkyl derivatives
BOEHRINGER INGELHEIM PHARMA35 citations90
US6043254AMar 28, 2000
Indolinones having kinase-inhibiting activity
BOEHRINGER INGELHEIM PHARMA27 citations90
US6855710B2Feb 15, 2005
Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs
BOEHRINGER INGELHEIM PHARMA14 citations83
US6319918B1Nov 20, 2001
Substituted indolinones with kinase inhibitory activity
BOEHRINGER INGELHEIM PHARMA10 citations74
US6545035B1Apr 8, 2003
Substituted indolinones with kinase inhibitory activity
BOEHRINGER INGELHEIM PHARMA2 citations63
BOEHRINGER SOHN INGELHEIM
4 patentsUS4010279AMar 1, 1977
Biphenyloxy derivatives and antihyperlipidemic use
BOEHRINGER SOHN INGELHEIM39 citations92
US3987047AOct 19, 1976
Tetrahydro-azepinoquinolines
BOEHRINGER SOHN INGELHEIM29 citations82
US4343811AAug 10, 1982
2[3-(4-Chlorophenyl)-1,2-dimethyl-1H-indol-5-yloxy]-2-methyl propanoic acid and hyperlipidemic or atheosclerotic use thereof
BOEHRINGER SOHN INGELHEIM12 citations72
US4042711AAug 16, 1977
Derivatives of biphenyloxy-lower alkanoic acids, salts thereof and their use as antihyperlipidemics
BOEHRINGER SOHN INGELHEIM3 citations62